The Cancer Center’s Small Animal Imaging Core provides instrumentation and expertise for quantitative analysis of tumor growth and metastasis in live animals.
Equipment includes a state-of-the-art Xenogen IVIS 200 Biophotonic Imager, a Leica MZ-FLIII QImaging Fluorescence Stereo Imaging System, a surgical workstation and a full tissue/cell culture laboratory.
In addition to instrumentation, the core provides services for creation and use of imagable human and mouse xenograft models and for viral expression of cDNAs and siRNAs for analysis of gene function in tumor growth and metastasis. Equipment and services provided by the core can be used for drug target identification and verification and evaluation of drugs and therapeutic approaches for intervention of cancer progression.
A technician is available for introduction of tumor cells into animals, animal handling/husbandry, organ dissection, and preparation of tissues for pathological examination and gene expression analysis. Additional equipment and services will be added over the next three years to support and extend the facility’s current capabilities.
Animal Pathology Core + Animal Histology Core
The Animal Pathology Core (APC) and Animal Histology Core provide research pathology and histology services for investigators using laboratory animals.
The Animal Pathology Core strives to provide exceptional services. Final slide quality is a combined result of proper collection technique; trimming and placement in appropriate cassettes to avoid tissue damage or loss; fixation; processing; sectioning; and staining. Please ask our staff for assistance with any techniques you are not experienced with. The final slide quality will be a reflection of work from both your lab and ours.
Transgenic Core Facility
The Tufts Medical Center Transgenic Core Facility (TCF) is a fully functioning, state-of-the-art transgenic facility with the requisite resources and expertise to continue to develop novel transgenic, knockout, knock-in and related genetic mouse models for the study of human cancer diseases. The TCF is actively involved in such studies at present and provides many services to the Cancer Center investigative community.